Next Article in Journal
Shoulder Isokinetic Strength Deficit in Patients with Neurogenic Thoracic Outlet Syndrome
Next Article in Special Issue
Usability and Clinical Performance Characteristics of the Asante HIV1/2 Test by Trained Users in Two African Sites
Previous Article in Journal
Automatic Liver Viability Scoring with Deep Learning and Hyperspectral Imaging
Previous Article in Special Issue
COVID-19 Antibody Detecting Rapid Diagnostic Tests Show High Cross-Reactivity When Challenged with Pre-Pandemic Malaria, Schistosomiasis and Dengue Samples
 
 
Protocol
Peer-Review Record

Trial Design of a Prospective Multicenter Diagnostic Accuracy Study of a Point-of-Care Test for the Detection of Taenia solium Taeniosis and Neurocysticercosis in Hospital-Based Settings in Tanzania

Diagnostics 2021, 11(9), 1528; https://doi.org/10.3390/diagnostics11091528
by Chiara Trevisan 1,2,*,†, Inge Van Damme 2,†, Bernard Ngowi 3,4, Veronika Schmidt 5,6, Dominik Stelzle 5,7, Karen Schou Møller 8, Mwemezi Kabululu 9, Charles E. Makasi 3, Pascal Magnussen 10, Emmanuel Bottieau 11, Emmanuel Abatih 12, Maria V. Johansen 13, Helena Ngowi 14, Benedict Ndawi 15,‡, Kabemba E. Mwape 16, Gideon Zulu 16,17, Pierre Dorny 1, Andrea S. Winkler 5,6,§, Sarah Gabriël 2,*,§ and on behalf of the SOLID Consortium ‖
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Diagnostics 2021, 11(9), 1528; https://doi.org/10.3390/diagnostics11091528
Submission received: 8 July 2021 / Revised: 19 August 2021 / Accepted: 20 August 2021 / Published: 24 August 2021
(This article belongs to the Special Issue Point-of-Care Diagnostics for Low-Resource Settings)

Round 1

Reviewer 1 Report

The manuscript by Trevisan et al describes a trial design of a point-of-care test for the parasite Taenia solium. The manuscript is well written, except for a few minor points (see below). However, most of the authors already published a very similar protocol / study design. In this manuscript, the larger study population is described. Since the scope of the journal Diagnostics is to publish “original research articles, reviews, short communications, case reports and interesting images”, I do not see the value of an additional protocol without showing any data. Not even the initial results of the test accuracy were shown, but only referenced to as “data not shown” in the previous protocol published in Diagnostics. The study itself and the point-of-care test are both very important and valuable especially for resource-poor areas, but I am reluctant to suggest publishing of another extremely similar protocol  without showing data. The only difference of the protocol is the setting, number of tests produced and to be performed and the study population.  

If however, the editors consider the protocol for publication, I would ask to consider the following minor points:

Introduction:

  • Last paragraph page 3: “…for the detection of solium T and (N)CC in a resource-poor, highly…” à define T, e.g., put in brackets

Materials and methods:

  • Define the proteins (type) rESS33 & rT24H à in the reference you state, the protein is named TSES33, the other reference does not state a protein, but PCR primers, use the correct references here (e.g., doi: 4269/ajtmh.17-0310; doi: 10.1128/JCM.03260-13)
  • explain better that T-antibodies and CC-antibodies are to detect the parasite or disease
  • 11: the authors mention the sensitivity and specificity of the TSPOC and reference their own previous paper – however, these data were not shown in the paper, at least a summary of this should be shown and not just said “unpublished data”

Author Response

Please see attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

The paper describes an interesting study design, the simulatneous testing for taeniosis and (neuro-)cysticercosis in three patient cohorts in Tanzania.

While the study design seems approriate and follows the need for fast and reliable testing in resource-poor settings, the paper does not present any study results as - apparently - the study has not yet been performed. I strongly suggest to validate the mentioned test with 10 patients, run a pilot study with 10-30 pateints and present these limited results alongside the study design, and wait for the finalized WHO NCC management guidelines.

A bit confusing, the sentences are written in past tense as if the study had been performed already.

Author Response

Please see attachment.

Author Response File: Author Response.docx

Round 2

Reviewer 1 Report

Thank you for clarifying some aspects.

Reviewer 2 Report

Thank you for the clarification.

Back to TopTop